NCT06975644 2025-05-22Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)Zhejiang Provincial People's HospitalPhase NA Not yet recruiting55 enrolled